Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- NVRO +17.5%, CAMT +10.8%, EVGO +9.3%, TGI +7.9%, SE +6.5%, GRAB +6.4%, LYV +5.8%, AGO +5.5% (also increases repurchase plan), LAZR +4.9%, SHLS +4%, ONON +3.8%, HUYA +3.4%, TH +3.1%, SRRK +3%, AROC +2.9%, IBRX +2.6%, AXSM +2.2%, YALA +2.1%, GENI +2.1%, HD +1.8%, ROIV +1.6%, EGY +1.3%, LEGN +1.1%, IAC +0.8%
Other news:
- ORGO +12.3% (reports interim analysis of trial of ReNu)
- ZGN +2.2% (controlling shareholder Monterubello purchased 913,000 shares and intends to acquire additional 2 mln shares in the coming weeks)
- DOMO +2.1% (selected by Bond Vet for its tech platform)
- LIVN +1.3% (OSPREY study meets safety and efficacy endpoints)
- CAH +1.3% (acquires two strategic additions to its portfolio)
- BEN +0.8% (prelim month-end AUM)
- GILD +0.8% (Scientific Leadership Spotlighted as Gilead Presents Research Data Across Its Broad and Innovative HIV Treatment Portfolio and Pipeline)